In subset analyses, ASXL1 remained strongly associated with incidence of heart failure (37.7% vs 5.2%; P < .001), CAD (13.5% vs 3.2%; P = .01), and stroke (11.7% vs 1.2%; P < .001) (eTable 5 in Supplement 1). Here, ASXL1 is linked to heart failure.